One serious complication after coronary artery bypass graft surgery is hyperplastic growth of the transplant. Now, a U.S. team has reported that this hyperplasia is rooted in the endothelial cells lining the transplanted veins and has shown that blocking TGFbeta activity in mice prevents the cellular changes.